Thrombospondin-1 polymorphisms influence risk of corneal allograft rejection

Invest Ophthalmol Vis Sci. 2014 Apr 7;55(4):2115-20. doi: 10.1167/iovs.13-13681.

Abstract

Purpose: We investigated single nucleotide polymorphisms (SNPs) of thrombospondin-1 (TSP-1) on the risk of corneal allograft rejection. The TSP-1 is known to be involved in the immune response of the anterior chamber of the eye, activating TGF-β2, promoting peripheral and systemic tolerance, and counteracting the proangiogenic activity of VEGF.

Methods: Three tagging SNPs spanning the TSP-1 region (rs1478604, A>G; rs2228261, C>T; and rs2228262, A>G) were genotyped. Association with risk of rejection was investigated in a group of 378 corneal transplant recipients with risk factors for allograft rejection. Transplant recipients had completed 3-year follow-up.

Results: The TSP-1 rs1478604 A SNP was associated significantly with an increased risk of corneal allograft rejection (odds ratio [OR], 1.58; 95% confidence interval [CI], 1.02-2.45; P = 0.04) and there was a trend toward the rs1478604, rs2228261, rs2228262 ACA haplotype increasing risk of rejection.

Conclusions: The results suggest that TSP-1 rs1478604 AA homozygotes may be at increased risk of corneal transplant rejection, especially if they carry the ACA haplotype.

Keywords: corneal transplantation; single nucleotide polymorphism; thrombospondin-1.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Allografts
  • Corneal Diseases / surgery
  • Corneal Transplantation*
  • DNA / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Genotype
  • Graft Rejection / genetics*
  • Graft Rejection / metabolism
  • Graft Survival / genetics*
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Thrombospondin 1 / genetics*
  • Thrombospondin 1 / metabolism
  • Young Adult

Substances

  • Thrombospondin 1
  • DNA